Dynavax Technologies Corp Comparables
Find the most relevant public market comparables for Dynavax Technologies Corp, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The company leverages its proprietary vaccine adjuvant technology to address various medical needs. Its major product is Heplisav-B, a hepatitis B vaccine approved for use in adults. The company also has CpG 1018 adjuvant used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines, and is advancing a pipeline of vaccine candidates, including those for shingles and plague.
Business Model
Developing and commercializing novel vaccines.
Target Customers
Adults requiring vaccination against Hepatitis B, and vaccine developers utilizing CpG 1018 adjuvant.
Specific Focus
Vaccine development and commercialization, particularly focusing on adjuvants and vaccines for infectious diseases.
Location
Emeryville, California
CEO
Ryan Spencer
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
399%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Dynavax Technologies Corp in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Dynavax Technologies Corp? Our platform provides detailed analysis of Dynavax Technologies Corp's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Dynavax Technologies Corp compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Dynavax Technologies Corp Compset
As a leading player in the Life sciences industry within the Healthcare sector, Dynavax Technologies Corp operates in the specialized Biotechnology sub-sector. Understanding how Dynavax Technologies Corp compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Dynavax Technologies Corp and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free